Designing an AAV vector involves substituting viral genes with a gene of interest (GOI) framed by Inverted Terminal Repeats (ITRs). This allows the genetic material to be safely packaged into a capsid for efficient delivery. Key to this process is the careful selection of promoters, enhancer elements and serotypes to ensure precise expression.